However, it has low sensitivity and specificity when used in isolation, with its levels increasing in iron deficiency anemia and decreasing in liver diseases, sepsis, malabsorption and inflammatory changes.(47,48) In patients eligible for HSCT, multiple blood transfusions prevent transferrin from being a good evaluation parameter. The gene discussed is TF; the disease is anemia.